drugset
drugset / Trial / NCT00115804

Safety and Efficacy of Fluoxetine in Juvenile Fibromyalgia

NCT00115804 ↗

Phase 3 Completed 6 enrolled University of Cincinnati
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this research is to conduct an open, pilot trial to assess the efficacy and safety of fluoxetine in the treatment of Juvenile Primary Fibromyalgia Syndrome (JPFS).

Timeline

Start
2005-06
Primary completion
2011-02
Completion
2011-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluoxetine Small molecule 10 mg Oral
Subject Fluoxetine Small molecule 60 mg Oral

Indications

fibromyalgia